{
    "Trade/Device Name(s)": [
        "Sofia Lyme FIA",
        "Sofia Lyme Control Set"
    ],
    "Submitter Information": "Quidel Corporation",
    "510(k) Number": "K163713",
    "Predicate Device Reference 510(k) Number(s)": [
        "K122979",
        "K122986"
    ],
    "Regulatory Class": "II",
    "Product Code(s)": [
        "LSR"
    ],
    "Summary Letter Date": "May 17, 2017",
    "Summary Letter Received Date": "May 19, 2017",
    "Submission Date": "October 18, 2017",
    "Regulation Number(s)": [
        "21 CFR 866.3830"
    ],
    "Regulation Name(s)": [
        "Treponema pallidum treponemal test reagents"
    ],
    "Analyte Class(es)": [
        "immunology",
        "microbiology"
    ],
    "Analyte(s)": [
        "IgM antibody to Borrelia burgdorferi",
        "IgG antibody to Borrelia burgdorferi"
    ],
    "Specimen Type(s)": [
        "Serum",
        "Plasma"
    ],
    "Specimen Container(s)": [],
    "Instrument(s)/Platform(s)": [
        "Sofia"
    ],
    "Method(s)/Technology(ies)": [
        "Immunofluorescence",
        "Lateral flow assay"
    ],
    "Methodologies": [
        "Immunofluorescence-based lateral flow"
    ],
    "Submission Type(s)": [
        "Assay",
        "Control",
        "Kit",
        "Test Cassette",
        "Quality control material"
    ],
    "Document Summary": "FDA 510(k) summary for Quidel Sofia Lyme FIA and Control Set immunofluorescence lateral flow assay for detection of Borrelia burgdorferi antibodies",
    "Indications for Use Summary": "Aids in the rapid differential detection of human IgM and IgG antibodies to Borrelia burgdorferi from serum and plasma specimens from patients suspected of Lyme disease; Control Set verifies Sofia Lyme FIA performance",
    "fda_folder": "Microbiology"
}